PE: How will recent regulatory developments at FDA impact feasibility assessments in clinical planning? Woollett: It’s ...

In today’s Pharmaceutical Executive Daily, the FDA introduces a new superiority standard for future CAR-T approvals, Relation ...

Fondazione Telethon announced that FDA has approved its Biologics License Application (BLA) for Waskyra (etuvetidigene ...

With only 11% of organizations reporting comprehensively organized and accessible data for AI applications, data readiness ...

Several high-quality systemic reviews also found that pharmacist- and nurse-led interventions—such as patient education, ...

How pharma marketers can time brand messages to prescribers when it matters most.

The collaboration agreement joins Relation’s AI-powered drug discovery platform and human data generation capabilities with ...

Pfizer announced it has entered into an exclusive global collaboration and license agreement with Chongqing Yao ...

Early real-world findings show that Carvykti, a BCMA-directed CAR T-cell therapy, is demonstrating sustained remissions in ...

Jaypirca is approved for the treatment of adults with relapsed or refractory CLL/SLL who were previously treated with a ...

Carvykti’s emerging Phase III data shows that a single early-line infusion can deliver durable, treatment-free remissions ...

For Phase III trial planning, two suggestions may have merit. Include sizeable subpopulations that payers cannot easily ...